Vertex Pharmaceuticals Incorporated
VRTXBiotechnology
$540.00+1.95%As of Oct 29vs prior close
- Market cap
- $136.8B
- P/E (TTM)
- 31.2×
- P/E (FY1)
- 30.2×
- From 52W high
- −3.22%
- EPS (LTM)
- $17.17
- Revenue (LTM)
- $12.6B
- Net margin
- 35.00%
- Dividend yield
- 0.00%
Nomior Score
83
Fortified DefenderTop 1% of the scored universe
Growth51
Quality86
Value63
Momentum76
Resilience72
Growth
+24.24%revenue a year over 9 fiscal years
YE16 $1.7BLTM $12.6B
Connections
Revenue to profitQ2 YE26
33% of revenue became net profit, down 2 pts on a year.
Who owns it
7funds, 1 tracked portfolio